Ascom's latest offering, Ascom Myco, a smartphone with unique features designed to render nurses' work easier, catches the interest of Belgian hospitals and healthcare institutions. Philippe Bosmans, Sales Manager, Ascom Belgium and Tom Decoo, Senior Account Manager Healthcare, Nextel, a Belgium-based telecoms integrator, explain the benefits of the Ascom Myco and the added value it brings to the hospitals.

Aridhia's data science platform AnalytiXagility has been chosen to underpin a €6 million oral healthcare innovation project funded by the EU’s Horizon 2020 programme and the funding win demonstrates huge confidence in Aridhia's data analytics capability.

Renowned health informatics leader Michael Thick has this week been appointed as chief medical officer (CMO) and chief clinical information officer (CCIO) of electronic patient record software pioneer IMS MAXIMS.

Dell has announced its extended partnership with Translational Genomics Research Institute (TGen) to help clinical researchers and doctors globally expand the reach and impact of the world's first Food and Drug Administration (FDA)-approved personalized medicine trial for pediatric cancer.

Virtualware Health today announced the release of VirtualRehab 3.0, the first clinically validated therapeutic video game solution for Hand & Body therapy with CE approval. Designed for professional therapists who work with patients that suffer from severe neurological conditions, VirtualRehab 3.0 will help patients to improve balance and fine motor skills using clinically tested therapeutic games and motion capture technology powered by Microsoft's® Kinect Xbox One and Leap Motion®.

New research shows that the quality of patient-physician communication, at the moment when additional oral type 2 diabetes (T2D) medication is prescribed ('add-on'), is linked to future patient self-care and well-being.(1) Data from the IntroDia™ Survey have quantitatively demonstrated this link in the largest international survey of its kind, using responses from 4,235 people with T2D across 26 countries.*(1)

University Hospital Southampton NHS Foundation Trust (UHS) and NantHealth today announced a strategic partnership with the aim of delivering and transforming cancer services using the most advanced molecular genomic and proteomic diagnostics, treatment decision support and unique IT integration capabilities for better informed precision treatment selection and care coordination.